Israel approves controversial plan to seize Gaza City, sparking international outcry and domestic opposition.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Trump administration battles courts over immigration enforcement, seeking to lift restrictions on practices found unconstitutional.
Israel approves controversial plan to seize Gaza City, sparking international outcry and domestic opposition.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Trump administration battles courts over immigration enforcement, seeking to lift restrictions on practices found unconstitutional.